“Obstructive sleep apnea (OSA) is a breathing disorder which is sleep related, marked by episodes of decreased and complete stoppage of ventilation (hypopnea and apnea)”. It is characterized by recurrent obstruction of upper airway in sleep leading to oxyhaemoglobin desaturation and arousals from deep sleep. According to recent study reports, it was found that approximately 936 million adults of age 30 to 69 years suffer from mild to moderate OSA worldwide. In India, the prevalence of OSA was 52 million as of 2021. OSA risk increases with the age. Also, males are more commonly affected.

OSA patients present with arousals from sleep at night, which are characterized by collapse of oropharyngeal airway. It results in excessive daytime sleepiness. Moreover, loud and bothersome snoring, choking and gasping during sleep are reported by the bed partners of these individual. This is accompanied by a change in breathing pattern. There is predominant thoracic breathing with a greater paradoxical motion of the abdomen. Moreover, patients with OSA tend to do oral and oro-nasal breathing in sleep.

The episodes of hypopnea and apnea during sleep are measured by polysomnography or home sleep testing with Apnea Hypopnea Index (AHI) being a vital measure of the test for OSA patients. Pharmacological management of OSA is not approved. However,S.G. Schütz et al. concluded in the systematic review that, pharmacological treatment can be used as an adjunct therapy as it has only mild to moderate effect on OSA severity. Besides, these medications have potential negative effects. Hence, the non-pharmacological management involving continuous positive airway pressure (CPAP) is considered as the first line of treatment. Evidences have showed the effectiveness of CPAP in decreasing the severity of OSA and improving sleep quality. However, there are side effects of CPAP which results in decreased adherence of patients to the treatment.

Myofunctional therapy serves as an adjuvant treatment for OSA patients. It involves isotonic and isometric oropharyngeal exercises, targeting the tongue and pharyngeal musculature. A recent systematic review by Rueda JR et al has established the positive effects of myofunctional therapy in OSA patients. In another study, R. Courtney et al. showed the effectiveness of functional nasal breathing rehabilitation technique on patients with nasal obstruction and self reported mouth breathing. It stated that these patients reported decreased mouth breathing, reduced snoring and improved sleep. Therefore further studies are needed on this technique in patients with impaired sleep.

Comprehensive rehabilitation for OSA focuses on modification of oral and oronasal breathing, improving oropharyngeal muscles and correcting paradoxical breathing pattern. It rehabilitates the patient through functional nasal breathing techniques, isotonic and isometric oropharyngeal exercises and diaphragmatic breathing technique.

To date, literatures have reported on usefulness of CPAP and myofunctional therapy as treatment approaches for OSA patients. Thus, a randomized controlled trial can be done to see the effectiveness of comprehensive rehabilitation for OSA. The primary objectives of the study are to determine the effect of comprehensive rehabilitation on AHI and excessive day time sleepiness. The secondary objectives are to determine its effect on oxygen desaturation, snoring, sleep quality and on the components of breathing dysfunction.